http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021107791-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d112629ffe022ebab46c4bee61f80a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a6a0d9b067060f4b0dcbb46203fe3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7e7cf6d9963b7d798dc3960432faf8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b8a4e5210a926014f9d4e1ac0ffd7f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e14abbe6ca14b8dfe3703ba5740e232 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4ff9129085baa6db9410bcc42e3d0b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d9de41e32440b211800c5e6717e3bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9efade62f3d4f790e91456f06696298 |
| publicationDate | 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021107791-A1 |
| titleOfInvention | Mirna biomarkers for differential diagnosis of histopathological subtypes of non-small cell lung cancer |
| abstract | This invention relates to a method for differential diagnosis in vitro of lung adenocarcinoma (AC) versus squamous cell lung carcinoma (SCC) in a subject, wherein the expression level for a panel of selected miRNA biomarkers is determined quantitatively and the miRNA signature is identified. This invention further relates to a method for differential diagnosis in vitro of squamous cell lung carcinoma (SCC) versus lung adenocarcinoma (AC) in a subject, wherein the expression level for a panel of selected miRNA biomarkers is determined quantitatively and the miRNA signature is identified. This invention further relates to a panel of selected miRNA biomarkers and uses of said panel of miRNA biomarkers in diagnostics. This invention further relates to a kit for differential diagnosis in vitro of lung adenocarcinoma versus squamous cell lung carcinoma comprising means for determining quantitatively the expression level of the panel of miRNA biomarkers and a kit for differential diagnosis in vitro of squamous cell lung carcinoma versus lung adenocarcinoma comprising means for determining quantitatively the expression level of the panel of miRNA biomarkers |
| priorityDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.